MetaADEDB 2.0 @ LMMD
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
(LHHCSNFAOIFYRV-DOVBMPENSA-N)
Structure
SMILES
O=C(NC(C)(C)C)N[C@@H](C(C)(C)C)C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(C(=O)C(=O)N)CC1CCC1)C2(C)C
Type(s)
Approved; Withdrawn
ATC code(s)
J05AP03
Molecular Formula:
C27H45N5O5
Molecular Weight:
519.677
Log P:
3.5221
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
4
TPSA:
150.7
CAS Number(s):
394730-60-0
Synonym(s)
1.
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
2.
Sch 503034
3.
Sch-503034
4.
Sch503034
5.
boceprevir
6.
victrelis
External Link(s)
MeSHC512204
PubChem Compound10324367
BindingDB12311
ChEBI68621
CHEMBLCHEMBL218394
DrugBankDB08873
DrugCentral4172
IUPHAR/BPS Guide to PHARMACOLOGY7876
KEGGdr:D08876
Therapeutic Target DatabaseD0V3YT
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 73SIDER
US FAERS
2DysgeusiaFAERS: 67SIDER
US FAERS
3NauseaFAERS: 49SIDER
US FAERS
4VomitingFAERS: 42SIDER
US FAERS
5No adverse eventFAERS: 36US FAERS
6PruritusFAERS: 32SIDER
US FAERS
7Weight decreasedFAERS: 32SIDER
US FAERS
8UrticariaFAERS: 27SIDER
US FAERS
9HeadacheFAERS: 26SIDER
US FAERS
10Adverse eventFAERS: 21US FAERS
11AstheniaFAERS: 18SIDER
US FAERS
12Dry skinFAERS: 17SIDER
US FAERS
13Product quality issueFAERS: 15US FAERS
14DizzinessFAERS: 14SIDER
US FAERS
15PneumoniaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
16LeukopeniaFAERS: 12SIDER
US FAERS
17MalaiseFAERS: 12
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
18NeutropeniaFAERS: 12SIDER
US FAERS
19AgitationFAERS: 11SIDER
US FAERS
20Drug dose omissionFAERS: 11US FAERS
21ThrombocytopeniaFAERS: 11SIDER
US FAERS
22White blood cell count decreasedFAERS: 11US FAERS
23Drug ineffectiveFAERS: 10
Canada Vigilance: 4
Canada Vigilance
US FAERS
24Inappropriate schedule of drug administrationFAERS: 10US FAERS
25AnxietyFAERS: 8SIDER
US FAERS
26Incorrect storage of drugFAERS: 8US FAERS
27PainFAERS: 8SIDER
US FAERS
28Back PainFAERS: 7SIDER
US FAERS
29Drug administration errorFAERS: 7US FAERS
30Mood swingsFAERS: 7SIDER
US FAERS
31SyncopeFAERS: 7SIDER
US FAERS
32ChillsFAERS: 6SIDER
US FAERS
33DyspepsiaFAERS: 6SIDER
US FAERS
34Memory impairmentFAERS: 6SIDER
US FAERS
35Mental status changesFAERS: 6SIDER
US FAERS
36PancytopeniaFAERS: 6SIDER
US FAERS
37StomatitisFAERS: 6SIDER
US FAERS
38treatment failureFAERS: 6US FAERS
39AlopeciaFAERS: 5SIDER
US FAERS
40Capsule physical issueFAERS: 5US FAERS
41ConstipationFAERS: 5SIDER
US FAERS
42Hepatitis CFAERS: 5US FAERS
43MyalgiaFAERS: 5SIDER
US FAERS
44Urinary tract infectionFAERS: 5SIDER
US FAERS
45Visual ImpairmentFAERS: 5SIDER
US FAERS
46Abdominal PainFAERS: 4SIDER
US FAERS
47AphagiaFAERS: 4US FAERS
48Cerebrovascular accidentFAERS: 4US FAERS
49Chest PainFAERS: 4SIDER
US FAERS
50Chest discomfortFAERS: 4SIDER
US FAERS
51DehydrationFAERS: 4SIDER
US FAERS
52DysuriaFAERS: 4SIDER
US FAERS
53Feeling abnormalFAERS: 4SIDER
US FAERS
54GastroenteritisFAERS: 4SIDER
US FAERS
55Incorrect dose administeredFAERS: 4US FAERS
56Incorrect product storageFAERS: 4US FAERS
57Product physical issueFAERS: 4US FAERS
58Pulmonary EmbolismFAERS: 4SIDER
US FAERS
59RetchingFAERS: 4US FAERS
60Viral load increasedFAERS: 4US FAERS
61Wrong technique in drug usage processFAERS: 4US FAERS
62Abdominal discomfortFAERS: 3SIDER
US FAERS
63Accidental exposure to productFAERS: 3US FAERS
64AmnesiaFAERS: 3SIDER
US FAERS
65CellulitisFAERS: 3SIDER
US FAERS
66Erythema MultiformeFAERS: 3SIDER
US FAERS
67FlushingFAERS: 3SIDER
US FAERS
68HypersensitivityFAERS: 3SIDER
US FAERS
69Limb discomfortFAERS: 3US FAERS
70NervousnessFAERS: 3US FAERS
71NocturiaFAERS: 3SIDER
US FAERS
72Oropharyngeal painFAERS: 3SIDER
US FAERS
73Psychiatric symptomFAERS: 3US FAERS
74RegurgitationFAERS: 3US FAERS
75SepsisFAERS: 3SIDER
US FAERS
76SomnolenceFAERS: 3US FAERS
77ThirstFAERS: 3US FAERS
78Accidental overdoseFAERS: 2US FAERS
79AngerFAERS: 2SIDER
US FAERS
80AngioedemaFAERS: 2SIDER
US FAERS
81ArthritisFAERS: 2SIDER
US FAERS
82AscitesFAERS: 2US FAERS
83BlindnessFAERS: 2US FAERS
84Blood count abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
85Blood creatinine increasedFAERS: 2US FAERS
86Blood glucose decreasedFAERS: 2US FAERS
87Blood glucose increasedFAERS: 2US FAERS
88Blood iron decreasedFAERS: 2US FAERS
89Blood urea increasedFAERS: 2US FAERS
90BronchitisFAERS: 2SIDER
US FAERS
91Cardiac ArrestFAERS: 2US FAERS
92ChokingFAERS: 2US FAERS
93Disease recurrenceFAERS: 2US FAERS
94ErythemaFAERS: 2SIDER
US FAERS
95Eye InfectionFAERS: 2US FAERS
96FormicationFAERS: 2US FAERS
97Gastric ulcerFAERS: 2US FAERS
98Gingival HyperplasiaFAERS: 2US FAERS
99HypotensionFAERS: 2SIDER
US FAERS
100InfectionFAERS: 2SIDER
US FAERS
101InfluenzaFAERS: 2SIDER
US FAERS
102Injection site pruritusFAERS: 2US FAERS
103Lip swellingFAERS: 2US FAERS
104LymphopeniaFAERS: 2SIDER
US FAERS
105Myocardial InfarctionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
106NasopharyngitisFAERS: 2SIDER
US FAERS
107Neutropenic sepsisFAERS: 2US FAERS
108Oral painFAERS: 2SIDER
US FAERS
109OverdoseFAERS: 2US FAERS
110PallorFAERS: 2SIDER
US FAERS
111PancreatitisFAERS: 2SIDER
US FAERS
112Poor quality drug administeredFAERS: 2US FAERS
113Pulmonary FibrosisFAERS: 2US FAERS
114Rash erythematousFAERS: 2SIDER
US FAERS
115Renal painFAERS: 2US FAERS
116SinusitisFAERS: 2SIDER
US FAERS
117Spinal column injuryFAERS: 2US FAERS
118StressFAERS: 2US FAERS
119SwellingFAERS: 2US FAERS
120ToothacheFAERS: 2US FAERS
121Toxicologic test abnormalFAERS: 2US FAERS
122Upper-airway cough syndromeFAERS: 2US FAERS
123AbscessFAERS: 1US FAERS
124AgeusiaFAERS: 1US FAERS
125Alanine Aminotransferase IncreasedFAERS: 1US FAERS
126Ammonia increasedFAERS: 1US FAERS
127Angina PectorisFAERS: 1US FAERS
128Antibody test abnormalFAERS: 1US FAERS
129Aortic AneurysmFAERS: 1US FAERS
130ArthralgiaFAERS: 1SIDER
US FAERS
131Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
132Atrial FibrillationFAERS: 1SIDER
US FAERS
133BedriddenFAERS: 1US FAERS
134Blood albumin decreasedFAERS: 1US FAERS
135Blood alkaline phosphatase increasedFAERS: 1US FAERS
136Blood cholesterol increasedFAERS: 1US FAERS
137Blood glucose abnormalFAERS: 1US FAERS
138Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
139Cataract operationFAERS: 1US FAERS
140CataractFAERS: 1US FAERS
141CheilitisFAERS: 1SIDER
US FAERS
142Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
143Completed SuicideFAERS: 1SIDER
US FAERS
144Coronary Artery DiseaseFAERS: 1SIDER
US FAERS
145CryingFAERS: 1US FAERS
146CystFAERS: 1SIDER
US FAERS
147DeafnessFAERS: 1SIDER
US FAERS
148Decreased immune responsivenessFAERS: 1US FAERS
149Deep Vein ThrombosisFAERS: 1SIDER
US FAERS
150Diabetes MellitusFAERS: 1SIDER
US FAERS
151Diabetes mellitus inadequate controlFAERS: 1US FAERS
152EmpyemaFAERS: 1US FAERS
153EpilepsyFAERS: 1US FAERS
154Eye painFAERS: 1SIDER
US FAERS
155Gastric infectionFAERS: 1US FAERS
156Genital HerpesFAERS: 1US FAERS
157GoutFAERS: 1SIDER
US FAERS
158HemiplegiaFAERS: 1US FAERS
159Hepatic cancer metastaticFAERS: 1US FAERS
160Hepatitis C RNA positiveFAERS: 1US FAERS
161HypothyroidismFAERS: 1SIDER
US FAERS
162Impaired work abilityFAERS: 1US FAERS
163Inadequate analgesiaFAERS: 1US FAERS
164InflammationFAERS: 1US FAERS
165Injection site bruisingFAERS: 1US FAERS
166Large intestinal stenosisFAERS: 1US FAERS
167Limb injuryFAERS: 1US FAERS
168LymphadenopathyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
169Medication ErrorFAERS: 1US FAERS
170MeningitisFAERS: 1US FAERS
171Musculoskeletal discomfortFAERS: 1SIDER
US FAERS
172Musculoskeletal stiffnessFAERS: 1US FAERS
173Nasal discomfortFAERS: 1US FAERS
174Neck PainFAERS: 1SIDER
US FAERS
175Pain of skinFAERS: 1US FAERS
176ParacentesisFAERS: 1US FAERS
177ParanoiaFAERS: 1SIDER
US FAERS
178Product dosage form issueFAERS: 1US FAERS
179Product taste abnormalFAERS: 1US FAERS
180Retinal DetachmentFAERS: 1US FAERS
181Retinal Vascular DisorderFAERS: 1US FAERS
182Retinal exudatesFAERS: 1SIDER
US FAERS
183Skin lesionFAERS: 1SIDER
US FAERS
184Squamous cell carcinomaFAERS: 1US FAERS
185Suicide attemptFAERS: 1SIDER
US FAERS
186Therapeutic product ineffectiveFAERS: 1US FAERS
187ThrombosisFAERS: 1US FAERS
188TinnitusFAERS: 1SIDER
US FAERS
189Unevaluable eventFAERS: 1US FAERS
190VertigoFAERS: 1SIDER
US FAERS
191Vulvovaginal rashFAERS: 1US FAERS
192Waist circumference increasedFAERS: 1US FAERS
193WheezingFAERS: 1SIDER
US FAERS
194Acute myocardial infarctionSIDER
195AgranulocytosisSIDER
196Anorectal discomfortSIDER
197ApathySIDER
198Aphthous StomatitisSIDER
199AspermiaSIDER
200Bipolar DisorderSIDER
201Bipolar I disorderSIDER
202Blood and lymphatic system disordersSIDER
203Blood triglycerides increasedSIDER
204Bone painSIDER
205CholecystitisSIDER
206ColitisSIDER
207ConjunctivitisSIDER
208DeliriumCanada Vigilance: 1Canada Vigilance
209DermatitisSIDER
210DiscomfortSIDER
211DysphoniaSIDER
212Ear and labyrinth disordersSIDER
213Ear discomfortSIDER
214EczemaSIDER
215EndophthalmitisSIDER
216EosinophiliaSIDER
217EpiglottitisSIDER
218EpistaxisSIDER
219Erectile dysfunctionSIDER
220Exfoliative rashSIDER
221Feeling of body temperature changeSIDER
222Flat affectSIDER
223FlatulenceSIDER
224GastritisSIDER
225Gastrointestinal PainSIDER
226GingivitisSIDER
227GlossitisSIDER
228Hepatitis C RNA increasedCanada Vigilance: 1Canada Vigilance
229HyperthyroidismSIDER
230Increased upper airway secretionSIDER
231InfestationSIDER
232Injection Site ReactionSIDER
233Joint swellingSIDER
234LethargySIDER
235Libido disorderSIDER
236MalnutritionSIDER
237MenorrhagiaSIDER
238Mental RetardationSIDER
239MetrorrhagiaSIDER
240Musculoskeletal PainSIDER
241Musculoskeletal chest painSIDER
242NeuralgiaSIDER
243Neutrophil count decreasedCanada Vigilance: 1Canada Vigilance
244Night sweatsSIDER
245NoduleSIDER
246Non-cardiac chest painSIDER
247OnychomycosisSIDER
248Optic NeuritisSIDER
249Oral fungal infectionSIDER
250Oropharyngeal blisteringSIDER
251Otitis MediaSIDER
252PalpitationsSIDER
253Pancreatic InsufficiencySIDER
254Pathogen resistanceCanada Vigilance: 4Canada Vigilance
255Pericardial effusionSIDER
256PericarditisSIDER
257PharyngitisSIDER
258PhotophobiaSIDER
259Pleuritic painSIDER
260Porphyria non-acuteSIDER
261PresyncopeSIDER
262PrurigoSIDER
263PsoriasisSIDER
264Psychiatric decompensationSIDER
265Respiratory FailureSIDER
266Respiratory tract congestionSIDER
267RhinitisSIDER
268SarcoidosisSIDER
269ShockSIDER
270Skin UlcerSIDER
271Stevens-Johnson SyndromeSIDER
272TachycardiaSIDER
273Thyroid NeoplasmSIDER
274Venous ThrombosisSIDER
275nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.